You are here

Article info

Article menu
Download PDFPDF
Therapeutics/Prevention
Systematic review
Evidence is weak to support hepatocellular carcinoma screening in chronic liver disease

Authors

  1. Correspondence to: Professor Simon D Taylor-Robinson, Department of Medicine, 10th Floor QEQM Wing, St Mary's Hospital Campus, Imperial College London, South Wharf Street, London W2 1NY, UK; s.taylor-robinson{at}imperial.ac.uk
View Full Text

Citation

Taylor-Robinson SD, Wong J, Crossey MME, et al
Evidence is weak to support hepatocellular carcinoma screening in chronic liver disease
BMJ Evidence-Based Medicine 2015;20:59.

Publication history

  • First published February 18, 2015.
Online issue publication 
October 21, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions